These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Avalanche for shape and feature-based virtual screening with 3D alignment. Diller DJ; Connell ND; Welsh WJ J Comput Aided Mol Des; 2015 Nov; 29(11):1015-24. PubMed ID: 26458937 [TBL] [Abstract][Full Text] [Related]
7. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Tropsha A; Golbraikh A Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786 [TBL] [Abstract][Full Text] [Related]
8. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors. Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418 [TBL] [Abstract][Full Text] [Related]
9. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design. Ebalunode JO; Zheng W; Tropsha A Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521 [TBL] [Abstract][Full Text] [Related]
10. 3D descriptors calculation and conformational search to investigate potential bioactive conformations, with application in 3D-QSAR and virtual screening in drug design. da Silva CHTP; Taft CA J Biomol Struct Dyn; 2017 Oct; 35(13):2966-2974. PubMed ID: 27739336 [TBL] [Abstract][Full Text] [Related]
11. Impact of conformational flexibility on three-dimensional similarity searching using correlation vectors. Renner S; Schwab CH; Gasteiger J; Schneider G J Chem Inf Model; 2006; 46(6):2324-32. PubMed ID: 17125176 [TBL] [Abstract][Full Text] [Related]
12. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes. Kumar SP; Jha PC Comb Chem High Throughput Screen; 2018; 21(1):26-40. PubMed ID: 29295689 [TBL] [Abstract][Full Text] [Related]
13. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques. Good AC; Cheney DL J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388 [TBL] [Abstract][Full Text] [Related]
14. Conformational sampling of bioactive molecules: a comparative study. Agrafiotis DK; Gibbs AC; Zhu F; Izrailev S; Martin E J Chem Inf Model; 2007; 47(3):1067-86. PubMed ID: 17411028 [TBL] [Abstract][Full Text] [Related]
15. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE. Hoffer L; Renaud JP; Horvath D J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132 [TBL] [Abstract][Full Text] [Related]
16. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents. Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952 [TBL] [Abstract][Full Text] [Related]
17. Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening. Chen IJ; Foloppe N J Chem Inf Model; 2008 Sep; 48(9):1773-91. PubMed ID: 18763758 [TBL] [Abstract][Full Text] [Related]